Twelve high-tech companies, including Biopôle member Legacy Healthcare, have been selected to participate in the second round of the LeadiNNg to Scale-Up program. A joint initiative of IMD and Innovaud, the program is designed to propel tech companies from promising startups to fast-growing, international scale-ups. As a novelty in 2023, the program opened its doors not only to Vaud-based ventures, but also to Swiss and international projects.
